Marvell Technology, Inc. Short-Term Borrowings increased by 0.0% to $499.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 286.0%, from $129.40M to $499.50M. Over 4 years (FY 2022 to FY 2026), Short-Term Borrowings shows an upward trend with a 75.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $193.27M | $41.39M | $52.21M | $63.20M | $74.10M | $653.50M | $584.00M | $584.40M | $1.52B | $1.02B | $96.30M | $107.30M | $118.30M | $129.30M | $129.40M | $129.50M | $1.26B | $499.30M | $499.50M |
| QoQ Change | — | -78.6% | +26.1% | +21.1% | +17.2% | +781.9% | -10.6% | +0.1% | +159.7% | -32.9% | -90.5% | +11.4% | +10.3% | +9.3% | +0.1% | +0.1% | +869.3% | -60.2% | +0.0% |
| YoY Change | — | — | — | — | -61.7% | >999% | >999% | +824.7% | >999% | +55.9% | -83.5% | -81.6% | -92.2% | -87.3% | +34.4% | +20.7% | +961.0% | +286.2% | +286.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.